Subacute cutaneous lupus erythematosus induction after SARS-CoV-2 Vaccine in a patient with primary biliary cholangitis.

We describe a subacute cutaneous lupus erythematosus (SCLE) case developed after vaccination with mRNA COVID-19 vaccine1 . A 30-year-old Italian woman presented due to the sudden occurrence of papules and plaques on her face and upper back. The eruption started following a day spent outdoors, ten days after receiving the SARS-CoV-2 mRNA vaccine second dose (Pfizer, Cominarty). At the time of our consultation, we observed purplish, erythematous and scaly papules and plaques on the upper back [Image 1A], cheeks, temples and forehead [Image 2A]. The rest of the skin was unaffected.